Buy or sell American Gene Technologies International stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

American Gene Technologies International Stock

American Gene Technologies develops bio-safe lentivirus therapies to treat cancer, HIV/AIDS, and other chronic human disorders.

About American Gene Technologies International Stock

American Gene Technologies is a gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications. It develops bio-safe lentivirus therapies to treat cancer, HIV/AIDS, and other chronic human disorders. The company's mission is to leverage the power of gene and cell therapy to reduce human suffering from serious human diseases. American Gene Technologies was established in 2007 and is headquartered in Rockville, Maryland.

Funding History

September 2013$1.3M
October 2014$340K

Management

CEO & Founder

Jeffrey A. Galvin

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 280K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo